american journal of nephrology

[1] Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary Hyperparathyroidism.

[2] anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism

[3] effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism

[4] the pleiotropic effects of paricalcitol: beyond bone-mineral metabolism

[5] Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS).

[6] Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary Hyperparathyroidism.

[7] fibroblast growth factor 23 and klotho protein in the pathogenesis of secondary hyperparathyroidism

[8] treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide

[9] anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism

[10] maxillary and frontal bone simultaneously involved in brown tumor due to secondary hyperparathyroidism in a hemodialysis patient

[11] effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism